Buzzing Politics
  • News
  • Privacy Policy
  • Terms of Use
  • Disclaimer
Select Page

Trump Bought Up To $5 Million In Axon Stock Weeks Before ICE Sought $220 Million Taser Contract: Report

by Namrata Sen | Jun 29, 2026

President Donald Trump reportedly bought up to $5 million worth of shares in Axon Enterprise (NASDAQ:AXON) — the maker of Tasers, body cameras, and...

Apple Tests Pricing Power As Component Costs Quadruple: Where Is AAPL Stock Headed?

by Henry Khederian | Jun 29, 2026

Apple Inc (NASDAQ:AAPL) shares are trading marginally higher Monday morning as AI-driven supply crunch headlines keep the focus on component...

FDA Manufacturing Issues Delay Lantheus’ Tumor Imaging Kit

by Vandana Singh | Jun 29, 2026

On Friday, the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter to Lantheus Holdings Inc.’s (NASDAQ:LNTH) New Drug...

Tom Lee’s BitMine Buy 27,084 ETH, But BMNR Hits Fresh Lows: What’s Going On?

by Parshwa Turakhiya | Jun 29, 2026

Bitmine Immersion Technologies (NYSE:BMNR) bought 27,084 Ethereum (CRYPTO: ETH) last week, pushing total holdings to 5.70 million ETH, even as the...

EXCLUSIVE: AMASS Targets Protein Craze With HpO Deal

by Akanksha Bakshi | Jun 29, 2026

AMASS Brands Group (NASDAQ:AMSS) said Monday it plans to acquire a majority stake in sparkling protein water brand HpO, expanding its presence in...

Nasdaq Jumps More Than 1%; Comcast Shares Spike Higher

by Avi Kapoor | Jun 29, 2026

U.S. stocks traded higher this morning, with the Nasdaq Composite gaining more than 1% on Monday. Following the market opening Monday, the Dow...

Airline Stocks Spent 6 Years Below Covid Highs: Hormuz Snapped That Trend In Two Months

by Piero Cingari | Jun 29, 2026

The U.S. Global Jets ETF (NYSE:JETS), the most widely watched gauge of global aviation, climbed 13.5% in June. That’s the best performance of any...

Viridian Secures First FDA Approval, Sets Up Challenge To Amgen’s Tepezza For Thyroid Eye Disease

by Vandana Singh | Jun 29, 2026

The U.S. Food and Drug Administration on Friday approved Viridian Therapeutics Inc.’s (NASDAQ:VRDN) new thyroid eye disease (TED) treatment, Lumvoa...

Zymeworks Targets Long-Term Cash Generation Through Theravance Acquisition

by Vandana Singh | Jun 29, 2026

Zymeworks Inc. (NASDAQ:ZYME) said Monday it has agreed to acquire Theravance Biopharma Inc. (NASDAQ:TBPH) in an all-cash transaction valued at about...

Zymeworks Targets Long-Term Cash Generation Through Theravance Acquisition

by Vandana Singh | Jun 29, 2026

Zymeworks Inc. (NASDAQ:ZYME) said Monday it has agreed to acquire Theravance Biopharma Inc. (NASDAQ:TBPH) in an all-cash transaction valued at about...

Rocket Lab Is Buying Iridium—Here’s Why Investors Are Excited

by Akanksha Bakshi | Jun 29, 2026

Rocket Lab Corp. (NASDAQ:RKLB) and Iridium Communications Inc. (NASDAQ:IRDM) announced Monday that they have entered into a definitive agreement...

Churchill Capital Stock Surges On $2.5B Merger With Agility Robotics: What Investors Need To Know

by Henry Khederian | Jun 29, 2026

Shares of Churchill Capital Corp XI (NASDAQ:CCXI) are trading higher Monday morning following last week’s announcement of a definitive business...

Churchill Capital Stock Surges On $2.5B Merger With Agility Robotics: What Investors Need To Know

by Henry Khederian | Jun 29, 2026

Shares of Churchill Capital Corp XI (NASDAQ:CCXI) are trading higher Monday morning following last week’s announcement of a definitive business...

Comcast To Separate Into Two Public Companies In Tax-Free NBCUniversal Spin-Off — Stock Rises

by Dylan Berman | Jun 29, 2026

Comcast Corporation (NASDAQ:CMCSA) shares are trading higher after the company announced it will separate into two independent publicly traded...

Comcast To Separate Into Two Public Companies In Tax-Free NBCUniversal Spin-Off — Stock Rises

by Dylan Berman | Jun 29, 2026

Comcast Corporation (NASDAQ:CMCSA) shares are trading higher after the company announced it will separate into two independent publicly traded...

« Older Entries
Next Entries »
  • News
  • Privacy Policy
  • Terms of Use
  • Disclaimer
Copyright 2019 Karmaholic Media LLC. All Rights Reserved.